NASDAQ:ZIVO • US98978N3098
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZIVO BIOSCIENCE INC (ZIVO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-06-04 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-12-15 | Maxim Group | Initiate | Buy |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 20K | -100.00% | 816K | ||||
| EBITDA YoY % growth | -6.13M 2.85% | N/A | N/A | -8.126M | -8.24M -1.39% | -8.361M -1.47% | |
| EBIT YoY % growth | -6.13M 3.16% | -8.35M -36.22% | -8.56M -2.51% | -8.149M -0.93% | -8.316M -1.04% | -8.685M 0.51% | |
| Operating Margin | N/A | N/A | -42,800.00% | N/A | N/A | -1,064.38% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.16 | -0.88 -379.88% | -0.82 85.38% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
7 analysts have analysed ZIVO and the average price target is 36.72 USD. This implies a price increase of 3238.18% is expected in the next year compared to the current price of 1.1.
The number of analysts covering ZIVO BIOSCIENCE INC (ZIVO) is 7.